Elevance Health (ELV) Stock: Buy, Sell, or Hold?
ELV - Elevance Health, Inc.
$381.67
-7.15 (-1.84%)
▼
5d:
-4.16%
30d:
-5.3%
90d:
-8.67%
WAIT
LOW Confidence
Analysis Updated: Oct 1, 2026 12:00 AM ET
Earnings: Oct 20, 2026
17d
Get Alerted When ELV Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
📊 MIXED SIGNALS: ELV shows conflicting indicators. Wait for confirmation before entering.
📊 MIXED SIGNALS: ELV shows conflicting indicators. Wait for confirmation before entering.
Long-Term Wealth Forecast (2031)
Based on Analyst Consensus Growth & Historical Valuation
0% (Stagnation)
50% (Hyper Growth)
EST. PRICE IN 2031
$506.05
Based on 6.4% avg growth
INTRINSIC VALUE TODAY
$314.22
Trading above historical range
How this is calculated: We use a Growth Decay Model: starting with analyst consensus growth (adjusted above) and gradually slowing it down to a long-term terminal rate (4%) by Year 5. This provides a more realistic valuation than assuming constant hyper-growth. We then apply a 12.6x Exit PE.
In-depth Analysis How we analyze
Valuation Analysis: ELV is currently trading at $381.67, which is considered oversold relative to its 30-day fair value range of $393.57 to $413.39. The stock's valuation (Forward PE: 12.9) is in line with its historical norms (12.6). At these levels, the market is pricing in 0.9% annual earnings growth.
Technical Outlook: Technically, ELV is showing sideways momentum. The price is currently testing key support at $375.74. A bounce from this level would confirm strength, while a break below could signal further downside.
Market Sentiment: ELV scores 26/100 on our bottoming-setup gauge. Note this measures entry quality, not trend direction — a low score can mean the chart is extended after a strong run (don't chase) or still falling without stabilization; better entries typically come after a pullback toward the 20-day average. In the options market, Implied Volatility is low (0th percentile), suggesting options premiums are relatively cheap. This makes it an attractive time for long options strategies if you have a directional bias. Wall Street analysts see significant upside, with an average price target of $451.38 (+18.3%). Current signals suggest waiting for a better entry point before initiating new positions.
Technical Outlook: Technically, ELV is showing sideways momentum. The price is currently testing key support at $375.74. A bounce from this level would confirm strength, while a break below could signal further downside.
Market Sentiment: ELV scores 26/100 on our bottoming-setup gauge. Note this measures entry quality, not trend direction — a low score can mean the chart is extended after a strong run (don't chase) or still falling without stabilization; better entries typically come after a pullback toward the 20-day average. In the options market, Implied Volatility is low (0th percentile), suggesting options premiums are relatively cheap. This makes it an attractive time for long options strategies if you have a directional bias. Wall Street analysts see significant upside, with an average price target of $451.38 (+18.3%). Current signals suggest waiting for a better entry point before initiating new positions.
Quick Decision Summary
Current Position
OVERSOLD
Historical Trading Range
$393.57 -
$413.39
Company Quality Score
44/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
66.2%
Protect Your Profits
Holding ELV? Use our AI-powered strategies to protect your downside while keeping your long-term position.
View Profit Protection PlanAll Signals
- BULLISH: Price oversold vs 30-day range
- BULLISH: Options cheap (IV 0th percentile)
- BEARISH: Weak technical setup (26/100)
- BULLISH: High volume confirmation
- BULLISH: Trading below Wall St target ($451.38)
- BULLISH: Expecting earnings turnaround to 0.9% growth with 1.4% revenue growth
- WARNING: Composite score 44/100 in the bottom quintile — this cohort historically lags the market
Trading Range Analysis
30-Day Trading Range
$393.57 -
$413.39
Current vs Trading Range
OVERSOLD
Expected Move (7 Days)
±$19.10
(5.0%)
Support & Resistance Levels
Support Level
$375.74
Resistance Level
$415.36
Current Trend
Sideways
Technical data as of
Oct 1, 2026
Fundamental Context
Forward P/E (Next Year Est.)
12.92
Wall Street Target
$451.38
(+18.3%)
Revenue Growth (YoY)
1.4%
Earnings Growth (YoY)
-13.1%
Profit Margin
2.5%
Valuation Premium vs History
+0.9% premium
PE vs Historical
12.9 vs 12.6
FAIR
Market-Implied Price Targets
If current PE multiple persists
Implied Growth (YoY):
+0.9%
(market-implied from PE analysis)
1-Year Target
$385.11
(+1%)
2-Year Target
$388.57
(+2%)
3-Year Target
$392.07
(+3%)
3-Yr Target (if PE normalizes)
(PE: 13→13)
PE COMPRESSION
$382.34
(+0%)
Earnings growth offset by PE compression
3-Year Scenarios
Using analyst projected EPS growth
Bull:
(PE: 20.4, Growth: 8.7%)
$774.72
(+103%)
Base:
(SPY PE: 12.9, Growth: 8.7%)
$490.68
(+29%)
Bear:
(PE: 11.0, Growth: 8.7%)
$417.08
(+9%)
📈
Valuation based on Current Earnings
RECOVERY PLAY: Stock looks expensive now (17x PE), but valuation improves significantly next year (13x PE) as earnings recover.
Trailing PE: 17.18 | Current EPS (TTM): $22.63
Bull Case
$558.29
(+46%)
Analyst growth 30.5%, PE expands to 18.9
Base Case
$507.54
(+33%)
Market implied 30.5%, PE stable at 17.2
Bear Case
$264.40
(-31%)
Severe decline -20.0%, PE contracts to 14.6
These are projections based on PE multiples and EPS growth scenarios, not predictions. Actual results may vary significantly.
Share & Embed Analysis
Last updated: October 01, 2026 11:38 PM ET
Data refreshes hourly during market hours. Next update: 12:38 AM
Data refreshes hourly during market hours. Next update: 12:38 AM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is ELV showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Healthcare Plans Stocks
Top-rated stocks in Healthcare Plans by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
CVS
CVS Health Corp |
STRONG BUY
28 analysts |
$116 | 49 HOLD |
|
UNH
UnitedHealth Group Incor… |
STRONG BUY
27 analysts |
$482 | 50 HOLD |
|
CI
Cigna Corp |
STRONG BUY
25 analysts |
$342 | 51 HOLD |
|
HUM
Humana Inc |
HOLD
26 analysts |
$424 | 60 HOLD |
|
CNC
Centene Corp |
BUY
19 analysts |
$72 | 46 HOLD |
Advanced ELV Option Strategies
Professional options setups generated by AI based on today's ELV price and gamma walls.
